nextcure.com - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi NXTC
NextCure, Inc. is recognized as a pioneer in discovering new biological pathways for immune activation. Its expert status is confirmed by absolute EBITDA, where the figure stands at 0.00, illustrating a path toward a commercial monopoly through patent assets. High future margins are ensured by massive demand for fresh therapeutic targets and licensing deals with pharma behemoths.
NextCure - rincian analitis lan metrik utama (NXTC)
- nilai pasar lan prakiraan target analis:
- rincian nilai pasar emiten:
- informasi kapitalisasi buku:
- rincian struktur utang lan likuiditas bisnis:
Rasio Total Utang marang Ekuitas NextCure, Inc.|NXTC - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal NextCure Inc|NXTC - Utang perusahaan|Rasio utang marang nilai buku NextCure|NXTC - Utang jangka dawa perusahaan|Utang jangka cendhak NextCure|Likuiditas kritis nextcure.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
NXTC - Penghasilan resik|Bathi resik mangsa ngarep NextCure, Inc.|NXTC - Pangali P/E|Pangali mangsa ngarep rega marang bathi nextcure.com|NXTC - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan NextCure|NXTC - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku NextCure|NXTC - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan nextcure.com|NXTC - Wutah bathi saben saham ing taun lumaku|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep NextCure, Inc.
Analisis kabeh metrik perusahaan:NextCure Corporation - NXTC
This indicator measures the operational efficiency of the business, excluding the impact of depreciation and taxes to assess the company's ability to generate real cash flow. By analyzing the EBITDA cash volume, an investor can see the resilience of the NextCure, Inc. (NXTC) commercial model against geopolitical risks, which hinder the international certification of innovative cancer therapy drugs through supply chain disruptions and sanctions.
Pesaing NextCure, Inc. (NXTC)
NantKwest (IBRX) - Bathi sadurunge bunga, pajak, lan amortisasi|IMCR: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi JANX (januxrx.com)|RCUS: Bathi operasional EBITDA|ZYME - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Tango Pharma|Bathi operasional sadurunge ngurangi amortisasi Iovance Corp (IOVA)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Immatics N.V. (IMTX)|Bathi operasional sadurunge ngurangi amortisasi xencor.com XNCR|Compass Therapeutics, Inc. - Bathi operasional sadurunge ngurangi amortisasi|Bathi operasional EBITDA Replimune Group Inc REPL|LYEL - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|IPHA (Innate Pharma S.A) - Bathi operasional sadurunge amortisasi|pyxisoncology.com (PYXS) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi Compugen (CGEN)|Bathi operasional sadurunge ngurangi amortisasi IOBT|STRO - Bathi operasional sadurunge potongan amortisasi|Bathi operasional sadurunge ngurangi amortisasi INKT (MiNK)|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi HOWL|Bathi operasional EBITDA IMMX (Immix Biopharma)|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi ALXO|Cue Biopharma, Inc. - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi PDS Biotechnology|sonnetbio.com (SONN) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|MAIA Bio - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|LIMN (Liminatus Pharma) - Bathi operasional EBITDA|Bathi operasional EBITDA Lava Tx|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Leap Therapeutics, Inc. (LPTX)|INTS: Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Sensei Biotherapeutics, Inc. - Bathi operasional sadurunge ngurangi amortisasi|Theriva Corp (TOVX) - Bathi sadurunge bunga, pajak, lan amortisasi|GRTS - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|KA (kinetabio.com) - Bathi operasional sadurunge amortisasi|NEXI: Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Turnstone Biologics Corp. (TSBX)|Bathi operasional sadurunge ngurangi amortisasi VCNX|Bathi operasional sadurunge amortisasi HARP (Harpoon Therapeutics Corp)
